Resverlogix Corp. (TSE:RVX – Get Rating)’s share price shot up 1.7% during trading on Tuesday . The stock traded as high as C$0.30 and last traded at C$0.30. 2,400 shares traded hands during mid-day trading, a decline of 96% from the average session volume of 66,048 shares. The stock had previously closed at C$0.29.
Resverlogix Stock Up 12.1 %
The firm’s 50-day simple moving average is C$0.25 and its 200 day simple moving average is C$0.42. The stock has a market capitalization of C$80.93 million and a P/E ratio of -2.23.
Resverlogix (TSE:RVX – Get Rating) last issued its quarterly earnings results on Friday, May 13th. The biotechnology company reported C($0.01) EPS for the quarter. As a group, equities analysts anticipate that Resverlogix Corp. will post -0.22 EPS for the current fiscal year.
Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. It is developing apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, end-stage renal disease, and neurodegenerative diseases.
- There Are Different Types of Stock To Invest In
- Is it Time to Tap Molson Coors or Will Beer Sales Turn Flat?
- Is Starbucks Shooting For The Moon?
- Two High-Yield Deep-Values You Shouldn’t Ignore
- PayPal Continues To Struggle As Competition Increases
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.